PMID- 17706035
OWN - NLM
STAT- MEDLINE
DCOM- 20071030
LR  - 20151119
IS  - 1008-8830 (Print)
IS  - 1008-8830 (Linking)
VI  - 9
IP  - 4
DP  - 2007 Aug
TI  - [Juvenile psoriatic arthritis].
PG  - 339-42
AB  - A case of juvenile psoriatic arthritis in a 12 year-old boy was reported. The 
      patient had a history of one and half a year of bilateral heel pain, followed by 
      pain in the right knee and ankle and right hip joint. He developed psoriatic 
      lesions affecting his nails and skin. He had increased erythrocyte sedimentation 
      rate (ESR) and C-reactive protein (CRP) contents. Human leukocyte antigen (HLA) 
      B27 was detected but serum rheumatoid factor was not in the patient. A skin 
      biopsy revealed psoriasis and ultrasonography demonstrated synovitis in right 
      knee and ankle. Juvenile psoriatic arthritis was diagnosed based on his physical, 
      laboratory and skin biopsy findings. A treatment with nonsteroidal 
      anti-inflammatory drugs and sulfasalazine produced no effect. Leflunomide in 
      conjunction with anti-TNF biologic agents (Etanercept) was administered, followed 
      by symptomatic improvement 2 weeks later.
FAU - Lu, Shan
AU  - Lu S
AD  - Department of Pediatrics, Peking University Third Hospital, Beijing 100083, 
      China. lucm@ccps.gov.cn
FAU - Zhou, Wei
AU  - Zhou W
FAU - Zhang, Qian
AU  - Zhang Q
FAU - Yu, Xin-Ying
AU  - Yu XY
FAU - Liu, Dong-Ming
AU  - Liu DM
FAU - Liu, Xiang-Yuan
AU  - Liu XY
LA  - chi
PT  - Case Reports
PT  - English Abstract
PT  - Journal Article
PL  - China
TA  - Zhongguo Dang Dai Er Ke Za Zhi
JT  - Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
JID - 100909956
RN  - 0 (Immunoglobulin G)
RN  - 0 (Receptors, Tumor Necrosis Factor)
RN  - 0 (Tumor Necrosis Factor-alpha)
RN  - OP401G7OJC (Etanercept)
SB  - IM
MH  - Arthritis, Psoriatic/diagnosis/*drug therapy/etiology
MH  - Child
MH  - Diagnosis, Differential
MH  - Etanercept
MH  - Humans
MH  - Immunoglobulin G/therapeutic use
MH  - Male
MH  - Receptors, Tumor Necrosis Factor/therapeutic use
MH  - Tumor Necrosis Factor-alpha/antagonists & inhibitors
EDAT- 2007/08/21 09:00
MHDA- 2007/10/31 09:00
CRDT- 2007/08/21 09:00
PHST- 2007/08/21 09:00 [pubmed]
PHST- 2007/10/31 09:00 [medline]
PHST- 2007/08/21 09:00 [entrez]
AID - 1008-8830(2007)04-0339-04 [pii]
PST - ppublish
SO  - Zhongguo Dang Dai Er Ke Za Zhi. 2007 Aug;9(4):339-42.